New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2012 |
---|---|
Erschienen: |
2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Bioorganic & medicinal chemistry - 20(2012), 16 vom: 15. Aug., Seite 4995-5001 |
Beteiligte Personen: |
Carneiro, Paula F. [VerfasserIn] |
---|
RVK: |
---|
Umfang: |
6 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1900926911 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1900926911 | ||
003 | DE-627 | ||
005 | 20230713095216.0 | ||
007 | tu | ||
008 | 120813s2012 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a sw120805_1 |
035 | |a (DE-627)OLC1900926911 | ||
035 | |a (DE-599)GBVOLC1900926911 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 540 |a 610 |
084 | |a PHARM |2 fid | ||
084 | |a VA 2619 |q AVZ |2 rvk | ||
100 | 1 | |a Carneiro, Paula F. |e verfasserin |4 aut | |
245 | 1 | 0 | |a New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms |
264 | 1 | |c 2012 | |
300 | |a 6 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a do Nascimento, Samara B. |4 oth | |
700 | 1 | |a Pinto, Antonio V. |4 oth | |
700 | 1 | |a Pinto, Maria do Carmo F.R. |4 oth | |
700 | 1 | |a Lechuga, Guilherme C. |4 oth | |
700 | 1 | |a Santos, Dilvani O. |4 oth | |
700 | 1 | |a dos Santos Júnior, Helvécio M. |4 oth | |
700 | 1 | |a Resende, Jackson A.L.C. |4 oth | |
700 | 1 | |a Bourguignon, Saulo C. |4 oth | |
700 | 1 | |a Ferreira, Vitor F. |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry |d Amsterdam [u.a.] : Elsevier, 1993 |g 20(2012), 16 vom: 15. Aug., Seite 4995-5001 |w (DE-627)171175506 |w (DE-600)1161284-8 |w (DE-576)038869047 |x 0968-0896 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2012 |g number:16 |g day:15 |g month:08 |g pages:4995-5001 |g extent:6 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
936 | r | v | |a VA 2619 |
951 | |a AR | ||
952 | |d 20 |j 2012 |e 16 |b 15 |c 8 |h 4995-5001 |g 6 |